Among the 66 enrolled patients with suspected MODY2, 28/66 were diagnosed as MODY2 based on mutations in the GCK gene (MODY2+) and 38/66 were MODY2-negative (MODY2−). This evidence concerns the gene GCK and maturity-onset diabetes of the young type 2.